1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
3
|
Zhang K, Song P, Gao J, Li G, Zhao X and
Zhang S: Perspectives on a combined test of multi serum biomarkers
in China: Towards screening for and diagnosing hepatocellular
carcinoma at an earlier stage. Drug Discov Ther. 8:102–109. 2014.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Romano M, De Francesco F, Pirozzi G,
Gringeri E, Boetto R, Di Domenico M, Zavan B, Ferraro GA and Cillo
U: Expression of cancer stem cell biomarkers as a tool for a
correct therapeutic approach to hepatocellular carcinoma.
Oncoscience. 2:443–456. 2015. View Article : Google Scholar : PubMed/NCBI
|
5
|
Inuzuka H, Shaik S, Onoyama I, Gao D,
Tseng A, Maser RS, Zhai B, Wan L, Gutierrez A, Lau AW, et al:
SCF(FBW7) regulates cellular apoptosis by targeting MCL1 for
ubiquitylation and destruction. Nature. 471:104–109. 2011.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Yeh CH, Bellon M and Nicot C: FBXW7: A
critical tumor suppressor of human cancers. Mol Cancer. 17:1152018.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Takeishi S and Nakayama KI: Role of Fbxw7
in the maintenance of normal stem cells and cancer-initiating
cells. Brit J Cancer. 111:1054–1059. 2014. View Article : Google Scholar : PubMed/NCBI
|
8
|
Davis RJ, Welcker M and Clurman BE: Tumor
suppression by the Fbw7 ubiquitin ligase: Mechanisms and
opportunities. Cancer Cell. 26:455–464. 2014. View Article : Google Scholar : PubMed/NCBI
|
9
|
Kawashita Y, Morine Y, Ikemoto T, Saito Y,
Iwahashi S, Yamada S, Higashijima J, Imura S, Ogawa H, Yagi T and
Shimada M: Loss of Fbxw7 expression is a predictor of recurrence in
colorectal liver metastasis. J Hepatobiliary Pancreat Sci.
24:576–583. 2017. View
Article : Google Scholar : PubMed/NCBI
|
10
|
Zhao Y, Wang M, Cui C, Zhang L, Liao F, Li
H and Wu X: Significance of combined tests of serum golgi
glycoprotein 73 and other biomarkers in diagnosis of small primary
hepatocellular carcinoma. Cancer Biomark. 15:677–683. 2015.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Wang X, Zhang J, Zhou L, Sun W, Zheng ZG,
Lu P, Gao Y, Yang XS, Zhang ZC, Tao KS and Dou KF: Fbxw7 regulates
hepatocellular carcinoma migration and invasion via Notch1
signaling pathway. Int J Oncol. 47:231–243. 2015. View Article : Google Scholar : PubMed/NCBI
|
12
|
Li G, Luna C, Qiu J, Epstein DL and
Gonzalez P: Alterations in microRNA expression in stress-induced
cellular senescence. Mech Ageing Dev. 130:731–741. 2009. View Article : Google Scholar : PubMed/NCBI
|
13
|
Ramalinga M, Roy A, Srivastava A,
Bhattarai A, Harish V, Suy S, Collins S and Kumar D: MicroRNA-212
negatively regulates starvation induced autophagy in prostate
cancer cells by inhibiting SIRT1 and is a modulator of angiogenesis
and cellular senescence. Oncotarget. 6:34446–34457. 2015.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Hermeking H: MicroRNAs in the p53 network:
Micromanagement of tumour suppression. Nat Rev Cancer. 12:613–626.
2012. View
Article : Google Scholar : PubMed/NCBI
|
15
|
Welch C, Chen Y and Stallings RL:
MicroRNA-34a functions as a potential tumor suppressor by inducing
apoptosis in neuroblastoma cells. Oncogene. 26:5017–5022. 2007.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Li R, Wu S, Chen X, Xu H, Teng P and Li W:
miR-223/FBW7 axis regulates doxorubicin sensitivity through
epithelial mesenchymal transition in non-small cell lung cancer. Am
J Transl Res. 8:2512–2524. 2016.PubMed/NCBI
|
17
|
Ibusuki M, Yamamoto Y, Shinriki S, Ando Y
and Iwase H: Reduced expression of ubiquitin ligase FBXW7 mRNA is
associated with poor prognosis in breast cancer patients. Cancer
Sci. 102:439–445. 2011. View Article : Google Scholar : PubMed/NCBI
|
18
|
Yu J, Zhang W, Gao F, Liu YX, Chen ZY,
Cheng LY, Xie SF and Zheng SS: FBW7 increases chemosensitivity in
hepatocellular carcinoma cells through suppression of
epithelial-mesenchymal transition. Hepatobiliary Pancreat Dis Int.
13:184–191. 2014. View Article : Google Scholar : PubMed/NCBI
|
19
|
Ding J, Zhao Z, Song J, Luo B and Huang L:
miR-223 promotes the doxorubicin resistance of colorectal cancer
cells via regulating epithelial-mesenchymal transition by targeting
FBXW7. Acta Biochim Biophys Sin (Shanghai). 50:597–604. 2018.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Lu G and Wang J: Dynamic changes in
routine blood parameters of a severe COVID-19 case. Clin Chim Acta.
508:98–102. 2020. View Article : Google Scholar : PubMed/NCBI
|
21
|
Gharaibeh L, Elmadany N, Alwosaibai K and
Alshaer W: Notch1 in cancer therapy: Possible clinical implications
and challenges. Mol Pharmacol. 98:559–576. 2020. View Article : Google Scholar : PubMed/NCBI
|
22
|
Vacca A, Felli MP, Palermo R, Di Mario G,
Calce A, Di Giovine M, Frati L, Gulino A and Screpanti I: Notch3
and pre-TCR interaction unveils distinct NF-kappaB pathways in
T-cell development and leukemia. EMBO J. 25:1000–1008. 2006.
View Article : Google Scholar : PubMed/NCBI
|
23
|
Wu J, Lu AD, Zhang LP, Zuo YX and Jia YP:
Study of clinical outcome and prognosis in pediatric core binding
factor-acute myeloid leukemia. Zhonghua Xue Ye Xue Za Zhi.
40:52–57. 2019.(In Chinese). PubMed/NCBI
|
24
|
Li Y, Guessous F, Zhang Y, Dipierro C,
Kefas B, Johnson E, Marcinkiewicz L, Jiang J, Yang Y, Schmittgen
TD, et al: MicroRNA-34a inhibits glioblastoma growth by targeting
multiple oncogenes. Cancer Res. 69:7569–7576. 2009. View Article : Google Scholar : PubMed/NCBI
|
25
|
Ji Q, Hao X, Zhang M, Tang W, Yang M, Li
L, Xiang D, Desano JT, Bommer GT, Fan D, et al: MicroRNA miR-34
inhibits human pancreatic cancer tumor-initiating cells. PLoS One.
4:e68162009. View Article : Google Scholar : PubMed/NCBI
|
26
|
Xiao G, Li Y, Wang M, Li X, Qin S, Sun X,
Liang R, Zhang B, Du N, Xu C, et al: FBXW7 suppresses
epithelial-mesenchymal transition and chemo-resistance of
non-small-cell lung cancer cells by targeting snai1 for
ubiquitin-dependent degradation. Cell Prolif. 51:e124732018.
View Article : Google Scholar : PubMed/NCBI
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
28
|
Agarwal V, Bell GW, Nam J and Bartel DP:
Predicting effective microRNA target sites in mammalian mRNAs.
eLife,. 4:e050052015. View Article : Google Scholar
|
29
|
Bilinska K, Jakubowska P, Von Bartheld CS
and Butowt R: Expression of the SARS-CoV-2 entry proteins, ACE2 and
TMPRSS2, in cells of the olfactory epithelium: Identification of
cell types and trends with age. ACS Chem Neurosci. 11:1555–1562.
2020. View Article : Google Scholar : PubMed/NCBI
|
30
|
Thompson WW, Shay DK, Weintraub E, Brammer
L, Cox N, Anderson LJ and Fukuda K: Mortality associated with
influenza and respiratory syncytial virus in the United States.
JAMA. 289:179–186. 2003. View Article : Google Scholar : PubMed/NCBI
|
31
|
Zhang H, Chen F, He Y, Yi L, Ge C, Shi X,
Tang C, Wang D, Wu Y and Nian W: Sensitivity of non-small cell lung
cancer to erlotinib is regulated by the Notch/miR-223/FBXW7
pathway. Biosci Rep. 37:BSR201604782017. View Article : Google Scholar : PubMed/NCBI
|
32
|
Sun XF, Sun JP, Hou HT, Li K, Liu X and Ge
QX: MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in
human hepatocellular carcinoma. Tumour Biol. 37:15325–15332. 2016.
View Article : Google Scholar : PubMed/NCBI
|
33
|
Kurashige J, Watanabe M, Iwatsuki M,
Kinoshita K, Saito S, Hiyoshi Y, Kamohara H, Baba Y, Mimori K and
Baba H: Overexpression of microRNA-223 regulates the ubiquitin
ligase FBXW7 in oesophageal squamous cell carcinoma. Br J Cancer.
106:182–188. 2012. View Article : Google Scholar : PubMed/NCBI
|
34
|
Wang Y, Liu Y, Lu J, Zhang P, Wang Y, Xu
Y, Wang Z, Mao JH and Wei G: Rapamycin inhibits FBXW7 loss-induced
epithelial-mesenchymal transition and cancer stem cell-like
characteristics in colorectal cancer cells. Biochem Biophys Res
Commun. 434:352–356. 2013. View Article : Google Scholar : PubMed/NCBI
|
35
|
Iwatsuki M, Mimori K, Ishii H, Yokobori T,
Takatsuno Y, Sato T, Toh H, Onoyama I, Nakayama KI, Baba H and Mori
M: Loss of FBXW7, a cell cycle regulating gene, in colorectal
cancer: Clinical significance. Int J Cancer. 126:1828–1837. 2010.
View Article : Google Scholar : PubMed/NCBI
|
36
|
Huang Z, Huang D, Ni S, Peng Z, Sheng W
and Du X: Plasma microRNAs are promising novel biomarkers for early
detection of colorectal cancer. Int J Cancer. 127:118–126. 2010.
View Article : Google Scholar : PubMed/NCBI
|
37
|
Li ZW, Yang YM, Du LT, Dong Z, Wang LL,
Zhang X, Zhou XJ, Zheng GX, Qu AL and Wang CX: Overexpression of
miR-223 correlates with tumor metastasis and poor prognosis in
patients with colorectal cancer. Med Oncol. 31:2562014. View Article : Google Scholar : PubMed/NCBI
|
38
|
Pichler M, Ress AL, Winter E, Stiegelbauer
V, Karbiener M, Schwarzenbacher D, Scheideler M, Ivan C, Jahn SW,
Kiesslich T, et al: miR-200a regulates epithelial to mesenchymal
transition-related gene expression and determines prognosis in
colorectal cancer patients. Br J Cancer. 110:1614–1621. 2014.
View Article : Google Scholar : PubMed/NCBI
|
39
|
Nishida N, Yokobori T, Mimori K, Sudo T,
Tanaka F, Shibata K, Ishii H, Doki Y, Kuwano H and Mori M: MicroRNA
miR-125b is a prognostic marker in human colorectal cancer. Int J
Oncol. 38:1437–1443. 2011.PubMed/NCBI
|
40
|
He D, Huang C, Zhou Q, Liu D, Xiong L,
Xiang H, Ma G and Zhang Z: HnRNPK/miR-223/FBXW7 feedback cascade
promotes pancreatic cancer cell growth and invasion. Oncotarget.
8:20165–20178. 2017. View Article : Google Scholar : PubMed/NCBI
|
41
|
Liu Z, Liu X, Liu S and Cao Q: Cholesterol
promotes the migration and invasion of renal carcinoma cells by
regulating the KLF5/miR-27a/FBXW7 pathway. Biochem Biophys Res
Commun. 502:69–75. 2018. View Article : Google Scholar : PubMed/NCBI
|
42
|
Sano H, Kawahito Y, Wilder RL, Hashiramoto
A, Mukai S, Asai K, Kimura S, Kato H, Kondo M and Hla T: Expression
of cyclooxygenase-1 and −2 in human colorectal cancer. Cancer Res.
55:3785–3789. 1995.PubMed/NCBI
|
43
|
Xu Y, Sengupta T, Kukreja L and Minella
AC: MicroRNA-223 regulates cyclin E activity by modulating
expression of F-box and WD-40 domain protein 7. J Biol Chem.
285:34439–34446. 2010. View Article : Google Scholar : PubMed/NCBI
|
44
|
Yeh CH, Bellon M, Pancewicz-Wojtkiewicz J
and Nicot C: Oncogenic mutations in the FBXW7 gene of adult T-cell
leukemia patients. Proc Natl Acad Sci USA. 113:6731–6736. 2016.
View Article : Google Scholar : PubMed/NCBI
|
45
|
Hua J, Ding T and Yang L: Dysfunction of
microRNA-32 regulates ubiquitin ligase FBXW7 in multiple myeloma
disease. Onco Targets Ther. 9:6573–6579. 2016. View Article : Google Scholar : PubMed/NCBI
|
46
|
Thomas MR, Marston L, Rafferty GF, Calvert
S, Marlow N, Peacock JL and Greenough A: Respiratory function of
very prematurely born infants at follow up: Influence of sex. Arch
Dis Child Fetal Neonatal Ed. 91:F197–F201. 2006. View Article : Google Scholar : PubMed/NCBI
|
47
|
Kumar V, Palermo R, Talora C, Campese AF,
Checquolo S, Bellavia D, Tottone L, Testa G, Miele E, Indraccolo S,
et al: Notch and NF-kB signaling pathways regulate miR-223/FBXW7
axis in T-cell acute lymphoblastic leukemia. Leukemia.
28:2324–2335. 2014. View Article : Google Scholar : PubMed/NCBI
|
48
|
Espinosa L, Cathelin S, D'Altri T,
Trimarchi T, Statnikov A, Guiu J, Rodilla V, Inglés-Esteve J,
Nomdedeu J, Bellosillo B, et al: The Notch/Hes1 pathway sustains
NF-κB activation through CYLD repression in T cell leukemia. Cancer
Cell. 18:268–281. 2010. View Article : Google Scholar : PubMed/NCBI
|
49
|
Senoo H, Kamimura Y, Kimura R, Nakajima A,
Sawai S, Sesaki H and Iijima M: Phosphorylated Rho-GDP directly
activates mTORC2 kinase towards AKT through dimerization with
Ras-GTP to regulate cell migration. Nat Cell Biol. 21:867–878.
2019. View Article : Google Scholar : PubMed/NCBI
|